365 related articles for article (PubMed ID: 15592895)
1. Deglycosylation of the NS1 protein of dengue 2 virus, strain 16681: construction and characterization of mutant viruses.
Crabtree MB; Kinney RM; Miller BR
Arch Virol; 2005 Apr; 150(4):771-86. PubMed ID: 15592895
[TBL] [Abstract][Full Text] [Related]
2. Mutagenesis of the N-linked glycosylation sites of the yellow fever virus NS1 protein: effects on virus replication and mouse neurovirulence.
Muylaert IR; Chambers TJ; Galler R; Rice CM
Virology; 1996 Aug; 222(1):159-68. PubMed ID: 8806496
[TBL] [Abstract][Full Text] [Related]
3. The envelope glycoproteins of dengue 1 and dengue 2 viruses grown in mosquito cells differ in their utilization of potential glycosylation sites.
Johnson AJ; Guirakhoo F; Roehrig JT
Virology; 1994 Sep; 203(2):241-9. PubMed ID: 8053148
[TBL] [Abstract][Full Text] [Related]
4. Essential role of dengue virus envelope protein N glycosylation at asparagine-67 during viral propagation.
Mondotte JA; Lozach PY; Amara A; Gamarnik AV
J Virol; 2007 Jul; 81(13):7136-48. PubMed ID: 17459925
[TBL] [Abstract][Full Text] [Related]
5. Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53.
Kinney RM; Butrapet S; Chang GJ; Tsuchiya KR; Roehrig JT; Bhamarapravati N; Gubler DJ
Virology; 1997 Apr; 230(2):300-8. PubMed ID: 9143286
[TBL] [Abstract][Full Text] [Related]
6. Glycosylation of the dengue 2 virus E protein at N67 is critical for virus growth in vitro but not for growth in intrathoracically inoculated Aedes aegypti mosquitoes.
Bryant JE; Calvert AE; Mesesan K; Crabtree MB; Volpe KE; Silengo S; Kinney RM; Huang CY; Miller BR; Roehrig JT
Virology; 2007 Sep; 366(2):415-23. PubMed ID: 17543367
[TBL] [Abstract][Full Text] [Related]
7. Selection and partial characterization of dengue 2 virus mutants that induce fusion at elevated pH.
Guirakhoo F; Hunt AR; Lewis JG; Roehrig JT
Virology; 1993 May; 194(1):219-23. PubMed ID: 8480420
[TBL] [Abstract][Full Text] [Related]
8. Critical role of Dengue Virus NS1 protein in viral replication.
Fan J; Liu Y; Yuan Z
Virol Sin; 2014 Jun; 29(3):162-9. PubMed ID: 24903593
[TBL] [Abstract][Full Text] [Related]
9. Mutation of Putative N-Glycosylation Sites on Dengue Virus NS4B Decreases RNA Replication.
Naik NG; Wu HN
J Virol; 2015 Jul; 89(13):6746-60. PubMed ID: 25878113
[TBL] [Abstract][Full Text] [Related]
10. The dengue virus type 2 envelope protein fusion peptide is essential for membrane fusion.
Huang CY; Butrapet S; Moss KJ; Childers T; Erb SM; Calvert AE; Silengo SJ; Kinney RM; Blair CD; Roehrig JT
Virology; 2010 Jan; 396(2):305-15. PubMed ID: 19913272
[TBL] [Abstract][Full Text] [Related]
11. Mutagenesis of the Dengue virus type 2 NS3 protein within and outside helicase motifs: effects on enzyme activity and virus replication.
Matusan AE; Pryor MJ; Davidson AD; Wright PJ
J Virol; 2001 Oct; 75(20):9633-43. PubMed ID: 11559795
[TBL] [Abstract][Full Text] [Related]
12. Chemical mutagenesis of dengue virus type 4 yields mutant viruses which are temperature sensitive in vero cells or human liver cells and attenuated in mice.
Blaney JE; Johnson DH; Firestone CY; Hanson CT; Murphy BR; Whitehead SS
J Virol; 2001 Oct; 75(20):9731-40. PubMed ID: 11559806
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the replication kinetics of the ChimeriVax-DEN 1, 2, 3, 4 tetravalent virus mixture in Aedes aegypti by real-time reverse transcriptase-polymerase chain reaction.
Johnson BW; Chambers TV; Crabtree MB; Guirakhoo F; Monath TP; Miller BR
Am J Trop Med Hyg; 2004 Jan; 70(1):89-97. PubMed ID: 14971704
[TBL] [Abstract][Full Text] [Related]
14. Characterization of dengue virus NS1 stably expressed in 293T cell lines.
Noisakran S; Dechtawewat T; Rinkaewkan P; Puttikhunt C; Kanjanahaluethai A; Kasinrerk W; Sittisombut N; Malasit P
J Virol Methods; 2007 Jun; 142(1-2):67-80. PubMed ID: 17331594
[TBL] [Abstract][Full Text] [Related]
15. Glycosylation mutants of dengue virus NS1 protein.
Pryor MJ; Wright PJ
J Gen Virol; 1994 May; 75 ( Pt 5)():1183-7. PubMed ID: 8176380
[TBL] [Abstract][Full Text] [Related]
16. Identification of human hnRNP C1/C2 as a dengue virus NS1-interacting protein.
Noisakran S; Sengsai S; Thongboonkerd V; Kanlaya R; Sinchaikul S; Chen ST; Puttikhunt C; Kasinrerk W; Limjindaporn T; Wongwiwat W; Malasit P; Yenchitsomanus PT
Biochem Biophys Res Commun; 2008 Jul; 372(1):67-72. PubMed ID: 18471994
[TBL] [Abstract][Full Text] [Related]
17. A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis.
Min JY; Li S; Sen GC; Krug RM
Virology; 2007 Jun; 363(1):236-43. PubMed ID: 17320139
[TBL] [Abstract][Full Text] [Related]
18. Multiple amino acid changes at the first glycosylation motif in NS1 protein of West Nile virus are necessary for complete attenuation for mouse neuroinvasiveness.
Whiteman MC; Wicker JA; Kinney RM; Huang CY; Solomon T; Barrett AD
Vaccine; 2011 Dec; 29(52):9702-10. PubMed ID: 21945257
[TBL] [Abstract][Full Text] [Related]
19. DNA vaccines against dengue virus based on the ns1 gene: the influence of different signal sequences on the protein expression and its correlation to the immune response elicited in mice.
Costa SM; Azevedo AS; Paes MV; Sarges FS; Freire MS; Alves AM
Virology; 2007 Feb; 358(2):413-23. PubMed ID: 17020777
[TBL] [Abstract][Full Text] [Related]
20. Restoration of replication-defective dengue type 1 virus bearing mutations in the N-terminal cytoplasmic portion of NS4A by additional mutations in NS4B.
Tajima S; Takasaki T; Kurane I
Arch Virol; 2011 Jan; 156(1):63-9. PubMed ID: 20882304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
